Last reviewed · How we verify

Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina Faso

NCT03269279 PHASE3 UNKNOWN

The goal of this study is to examine the effectiveness and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Burkina Faso.

Details

Lead sponsorGynuity Health Projects
PhasePHASE3
StatusUNKNOWN
Enrolment100
Start dateSat May 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionTue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

Burkina Faso